Acting for Hosen Capital in the closing of a single-asset continuation fund and the transfer of its existing investment in Kilcoy Global Foods, from Hosen’s USD Fund I to the new continuation fund and Hosen USD Fund III at a total purchase price of US$280 million
Acting for Sherpa Healthcare Partners in the raising of its debut USD healthcare fund at over US$200 million, and in the raising of its second USD healthcare fund at US$459 million
Acting for Eastern Bell Capital in the raising of its debut USD fund at US$365 million, and in the raising of its second USD fund at US$800 million, both focused on supply chain and logistics industries in China
Acting for Lilly Asia Ventures in the raising of various China focused life sciences funds, including LAV Biosciences Fund III (US$300 million), Fund IV (US$450 million), Fund V (US$750 million) and Fund VI (US$2.09 billion)
Acting for Hosen Capital in relation to the formation of Hosen PE Fund III, a US$800 million fund focused on food industry
Acting for CBC Group in the formation of its forth USD healthcare fund at over US$851 million
Acting for Ligang Zhang, founder, chairman and chief executive officer of iKang Healthcare Group, Inc. (Nasdaq: KANG) (“iKang”), as a member of the buyer consortium in the US$1.5 billion going private transaction of iKang
Acting for PAG Asia Capital in the formation of its third flagship private equity buyout fund at US$6 billion
Acting for Ocean Link in relation to the formation of Ocean Link Partners II, a US$580 million fund focused on travel and consumer industry
Acting for AGIC Capital in to the formation of AGIC Fund I, a US$1 billion relationfund focused on China-Europe cross-border investments
Acting for Orchid Asia in relation to the formation of Orchid Asia VI at US$920 million and Orchid Asia VII at over US$1.32 billion
Acting for Cedarlake Capital in relation to the formation of Cedarlake Fund I, a €296 million Germany-focused fund
Acting for Creador Capital in relation to the formation of Creador Capital Fund II, a US$300 million Southeast Asia-focused fund
Acting for Pagoda Investment in relation to the formation of Pagoda Investment Limited Partnership, a US$222 million China-focused fund
Acting for Lakeshore Capital Partners in relation to the formation of Lakeshore Capital I, a Thailand-focused fund
Acting for Long Hill Capital in relation to the formation of Long Hill Capital Fund I, a China-focused healthcare fund
